BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28813605)

  • 1. Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor.
    Ericson MD; Freeman KT; Schnell SM; Fleming KA; Haskell-Luevano C
    J Med Chem; 2017 Oct; 60(19):8103-8114. PubMed ID: 28813605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.
    Ericson MD; Koerperich ZM; Freeman KT; Fleming KA; Haskell-Luevano C
    ACS Chem Neurosci; 2018 Dec; 9(12):3015-3023. PubMed ID: 29924583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.
    Ericson MD; Wilczynski A; Sorensen NB; Xiang Z; Haskell-Luevano C
    J Med Chem; 2015 Jun; 58(11):4638-47. PubMed ID: 25898270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice.
    Fleming KA; Ericson MD; Freeman KT; Adank DN; Lunzer MM; Wilber SL; Haskell-Luevano C
    ACS Chem Neurosci; 2018 May; 9(5):1141-1151. PubMed ID: 29363944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Macrocyclic Agouti-Related Protein/[Nle
    Ericson MD; Freeman KT; Schnell SM; Haskell-Luevano C
    J Med Chem; 2017 Jan; 60(2):805-813. PubMed ID: 28045525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.
    Koerperich ZM; Ericson MD; Freeman KT; Speth RC; Pogozheva ID; Mosberg HI; Haskell-Luevano C
    J Med Chem; 2020 Mar; 63(5):2194-2208. PubMed ID: 31845801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.
    Fleming KA; Freeman KT; Ericson MD; Haskell-Luevano C
    J Med Chem; 2018 Sep; 61(17):7729-7740. PubMed ID: 30035543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptoid NPhe
    Ericson MD; Freeman KT; Haskell-Luevano C
    ACS Med Chem Lett; 2020 Oct; 11(10):1942-1948. PubMed ID: 33062177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
    Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
    Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
    Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
    Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
    J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
    Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
    J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Molecular Interactions of the Human Melanocortin-4 Receptor (hMC4R) Asp189 (D189) Amino Acid with the Endogenous G-Protein-Coupled Receptor (GPCR) Antagonist Agouti-Related Protein (AGRP) Provides Insights to AGRP's Inverse Agonist Pharmacology at the hMC4R.
    Ericson MD; Haslach EM; Schnell SM; Freeman KT; Xiang ZM; Portillo FP; Speth R; Litherland SA; Haskell-Luevano C
    ACS Chem Neurosci; 2021 Feb; 12(3):542-556. PubMed ID: 33470098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activity of neural melanocortin receptors.
    Tao YX; Huang H; Wang ZQ; Yang F; Williams JN; Nikiforovich GV
    Methods Enzymol; 2010; 484():267-79. PubMed ID: 21036237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
    Yang Z; Tao YX
    Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
    Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
    J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.